October 13, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Cosmederm receives $50 million from U.K. investment group
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Cosmederm Bioscience announced that Woodford Investment Management is investing $50 million into the company.
The capital from the investment will allow Cosmederm to grow its Refinity aesthetic brand, Tricalm over-the-counter dermatology brand and its drug development programs, according to a company press release.